High-end “no refunds” newsletter from Agora Financial that promises access to private placements and other non-public investment opportunities, mostly in gold mining.
“This rare private deal could score you up to 3,000% returns over time — or more!” That’s the attention-getting intro to the latest ad from Jim Rickards, who now has yet another paid newsletter service with Agora Financial — this one that he’s selling today is called Jim Rickards’ Private Dealflow, and it seems to […]
I’ve gotten quite a few questions about the “Cash from Gold” pitch out of Agora Financial that hints at how easy it is to get “instant income.” So that’s today’s focus for you, dear readers. The big push at the end of the ad is “Yes, I want to collect at least $1,500 per month […]
Options-selling newsletter from Zach Scheidt, offering weekly recommendations of options trades — advertised as selling put options.
Premium-priced newsletter that aims to ride the boom in defense spending by investing in smaller “defense technology” firms and contractors. Seems to have taken the place of Agora’s previous Military-Tech Alert.
The latest ad from Agora Financial’s Defense Technology Alert created a deluge of “what are those super contact lenses?” questions here at Stock Gumshoe, so as we dig out of the weekend teaser pile this one clearly rises to the “gotta answer it first” spot. What’s the story? Well, the ad is for Defense Technology […]
This ad touches a lot of bases… something that a newsletter claims has made people wealthy, is somewhat mysterious and secret, and is based on a legal catalyst that’s going to hit in just a few weeks, on March 16… … plus, it gives a newsletter pitchman the opportunity to call our politicians “those clowns […]
This is the intro from the ad we’re considering today: “Jim Rickards: Halfway to heaven, in a location with life-threatening temperatures, a little-known company is about to unleash… “‘God’s Gold’ “15 TIMES the concentration of the average global gold mine, this deposit contains arguably the highest-grade gold on the planet. “And one company trading for […]
Newsletter helmed by Jim Rickards and designed to profit from his expectation that gold will go to $10,000 — mostly picks gold and silver mining companies.
Newsletter promoters LOVE dates — using a specific day in the calendar, preferably a day within the next month or two, gives a sense of urgency to an ad and makes you feel like you have to sign up RIGHT NOW to avoid missing out on the profits that can be made. And Agora is […]
We’ve looked at a lot of Jim Rickards ads over the past couple of years, most of which either promise rapid-fire profits from currency options or predict huge gains for gold and, perhaps, a return to gold-backed money… today’s pitch is another one of the latter, it’s an ad for Rickards’ Strategic Intelligence. The hook […]
Jim Rickards, an economist and lawyer who has been peddling newsletters for Agora for a couple years, has a new ad out for his Strategic Intelligence newsletter that tries, as so many have for the past five years, to lather readers up into a panic about the imminent demise of the U.S. Dollar. And, of […]
“Entry level” newsletter for Jim Rickards, recommends trades based on his big-picture economic forecasting.
This week I’ve got a little teaser decipherization for you to get us started, and we’ve also got a new piece from Dr. KSS… and I’ve got some updated thoughts on a few other stocks at the end of today’s piece. The teaser? Well, it’s been circulating for a few weeks now, and it caught […]
Nikola Tesla has probably gotten more attention in the last five years than at any other time since he passed away during World War 2… for a while it was enough that the car company named after him was a daily headline generator and stock market darling, but now he’s also being connected to work […]
Bonner & Partners, which is yet another spinoff of Bill Bonner’s Agora publishing empire, has beefed up its newsletter offering a bit by launching a new newsletter that’s seems like it’s in the same vein as Agora’s Breakthrough Technology Alert — an expensive letter focused on new technologies and, more specifically, on the early stage […]
High-priced monthly newsletter that recommends stocks they think have “breakthrough” technology and high growth prospects. Brown also edits the lower-priced Near Future Report that seems to focus on larger or more established companies.
Another biotech teaser for you today — these never seem to stop, perhaps partly because small biotech stocks are almost the only ones, other than little junior miners, that have a legitimate chance of seeing their prospects change dramatically overnight or see rapid 100%, 200%, 500% share price gains on a new discovery or shockingly […]
Who can resist that headline, right? If for no other reason than you want to check and see if maybe you own that “next major U.S. stock” that former Reagan budget director David Stockman thinks is going down. That’s the headline from latest ad from Stockman’s Bubble Finance Trader newsletter service, which was launched fairly […]
Options trading advisory from former Reagan budget director David Stockman, who is looking for “bubble” stocks to bet against by buying put options (maybe other “bubble popping” trades as well, but put options are what has been promoted thus far).
Yes, that’s not my headline — I borrowed it from the ad I was asked to look at, the “special presentation for fast-moving readers” from Agora Financial’s Microcap Millionaires. The other possible headline would have been, also from the ad, “This Tiny Company Could Be The Next Household-Name Mega-Brand.” So you see, that’s not much […]
Today we’ve got a two-fer — two different big publishers are teasing different “liquid biopsy” stocks, and I’m no expert on the technology or the prospects for this diagnostic “trend” that we’ve been hearing more about… so I’ll just sift the clues, identify the companies, and let you chatter about their merits amongst yourselves. The […]
I know I’ve said this before, and sometimes it’s a lie: I’m going to try to keep this one brief. Agora Financial’s FDA Trader service has a new pitch out — which normally might not get that much attention, since everyone is suddenly terrified of biotech stocks after a brutal month or two — but […]
We see absurd hyperbole every day here at Stock Gumshoe, with promises of stocks that double or massive “free income” from various “top secret” trading strategies or… well, you know the drill, you get most of those same emails. So after swimming in this sea of hype for almost a decade, I sometimes forget just […]
Pain management is a huge market in the medical world, as you’re no doubt aware — and buckets of money are pouring down on the many, many little biotech stocks who are trying to develop new pain medications, or to tweak existing medications to make them safer or less likely to be abused. So it’s […]
Premium priced advisory from Byron King and Agora, largely focused on finding technology investments that started with military funding or have some defense connection, ranging from cybersecurity to biotech. Seems to have been succeeded at Agora by Defense Technology Alert.
I always like reading Chris Mayer’s stuff — he often presents at the Value Investing Congress, he seems to be an interesting and low-key guy in person, and the ideas that are pitched by his various newsletters at Agora often catch my eye. They don’t always work out, of course, but every once in a […]
This article was originally published on August 6, 2014 and the ad is circulating again and sending a lot of questions our way. The same stock is being touted and teased, and the original article below has not been updated or revised… the stock teased is up by about 50% since it was first teased, […]
Medical technology is always a prime area for investor excitement — we love the idea of a company that can make things bigger, cheaper, stronger, faster in any field of human endeavor, but somehow the idea of a company doing it in medicine, where we can feel both wealthy and virtuous after investing, is even […]
I’ve got a few thoughts for you on some companies I follow and own, and a little follow-up on last week’s chatter about hedge funds, but first I thought you’d like a quick teaser solution for your Friday File fun… The pitch is for Stephen Petranek’s Breakthrough Technology Alert — there’s been some discussion recently […]
Small cap stock-picking newsletter.
That’s right, the end of obesity. That’s what’s being touted by the new letter that as far as I can tell was just launched moments ago by Agora, which they’re calling FDA Trader and for which they apparently hired away Paul Mampilly from the Palm Beach Letter (OK, they didn’t really “hire him away” — […]
Biotech trading advisory/newsletter.
[ed note: Michael Jorrin is not a doctor but we like to call him “Doc Gumshoe,” he writes non-investment pieces for us about medical hype and health issues from time to time — today he indulged me by taking on a pitch from a health newsletter that caught my eye] The promotional piece – endless […]
What is it? “With one click of your mouse you could set yourself up to profit from: The rise of DNA-based personalized medicine; The “holy grail” new computers that could cure cancer; And a revolutionary new mass-produced ’30-minute oil.'”
This is a special bonus solution for the Irregulars, because the company is very, very small and probably quite foolish to trade — if you do buy it and the company doesn’t do well, it will be very hard to sell it quickly. Especially if you’re not willing to take substantial losses. That goes for […]
We first heard the “Chaffee Royalty” pitched a little more than five years ago, back when Chris Mayer was touting the “next Franco-Nevada” with a pitch about passive mining royalties — and, as you’ve probably guessed if you’ve read this far, it’s baaaaack! The basic idea of royalty investments is familiar to most Gumshoe readers […]
This article originally ran on January 8, 2013. It has not been updated save for the addition of this brief introductory note. More recent ad pitches on this same topic that say the stock and ticker have been “hacked” probably refer to our coverage of the story, but the more recent ads do not appear […]
Well, we’ve already covered one non-stock idea this week (that was the “Phi Account” pitch about philatelic investments) … so we might as well jump right in and look at another. This time, it’s a lot easier and is based on pocket change. And no, it’s not the same pitch for pre-1965 coins that have […]
Chris Mayer has a lengthy ad out now for his Special Situations newsletter, and in it he teases a handful of different ideas, from Mongolia to spin-off investing to S&L conversions … but there was one particular pitch in the ad that caught my eye. He says that he’s found a unique stock … and, […]
OK, you’re probably as sick of the “miracle materials” as I am, yes? But your friendly neighborhood Stock Gumshoe is nothing if not stubborn, and we got through the first two of Byron King’s Energy and Scarcity Investor teaser picks so now, dangit, we’re going to clear the slate and get that third one, too. […]
If you ever want a dose of optimism, just read through (or listen to) any of the ads for Breakthrough Technology Alert — Patrick Cox will have you swelling with rosy thoughts about a future without disease or hardship, with a nice dose of 1,000,000% returns thrown in … that, after all, is the raison […]
Now this is how a teaser ad should look! Any editor can promise huge gains — and heck, maybe even occasionally deliver on those dramatic gains if they get lucky or smart for a moment in time … but how many investment newsletters can tease that you’ll “live 20 years longer?” Here’s how Patrick Cox […]
I always feel a swell of optimism when I read a teaser ad from Patrick Cox — something about his relentless happy-facing about the teensy tiny technology and biotech companies he loves just stirs me up a little bit, reminds me that the reason many of us dabble in microcap stocks, little mining companies, new […]
Patrick Cox is not a shy guy. I don’t think I’ve ever read one of his biotech teaser ads that didn’t leave me convinced (at least for a moment) that the world was about to be changed because of the newest potion or pill that his favorite little companies were developing. And this latest one […]
The great Gumshoe faithful have been focused on one thing over the last couple days: what the heck is Byron King talking about with his “oil kitchen?” That term might sound familiar to you — King first recommended a stock using that “oil kitchen” phrase, referring to a large oil source area offshore Namibia, back […]
“… even with the ‘easy’ oil gone, you shouldn’t be surprised to hear more discoveries are coming online. Today I want to share with you a special way to profit from today’s newest oil finds. As you’ll see, it’s adventurous. Plus, it could be your way to profit from the next big find, before anyone […]
Today it’s time to come back to Chris Mayer, who’s teasing a small oil stock with a “magic drug” and that owns a massive $31.5 billion “oil bonanza” right here in the US of A. Sounds intriguing, right? Several of my readers thought so and passed it along, so let’s see if we can sleuthify […]
Commodities trading newsletter that recommends commodities futures options strategies.
Here’s the latest pitch from Chris Mayer for his Mayer’s Special Situations newsletter: “It’s the ONE resource more precious than oil, natural gas or gold. Without it, China’s growth — and the world’s — will likely come to a screeching halt. “Read on to discover the ONE tiny penny stock that has the breakthrough technology […]
“The New Alaskan ‘Oil Gush’ Is Underway… “Forget the greedy oil tycoons of Iraq, Saudi Arabia and Iran… Forget the oil giants Exxon, BP and Chevron… “This Tiny Exploration Company could deliver you a quick and early retirement…” That’s the intro from Chris Mayer in our newest tease — he’s trying to recruit new subscribers […]
Yes, the title of this article is misleading, dangerous crap. Sorry, but I just took it directly from the ad — the ad I’m writing about today is from Patrick Cox for his Breakthrough Technology Alert, a relatively expensive ($895) newsletter that focuses on, well, breakthrough technologies, mostly stocks that we’d classify as biotechs or […]
Patrick Cox is at it again with some teaseriffic promises — this time, we’re told that … “This is a Rare Opportunity to Own a Little-Known Biotech Company that’s Making Medical History…” Of course, nearly everything that passes through the floodgates here at Gumshoe HQ is a “rare opportunity” … otherwise, why on earth would […]
Yesterday I wrote to you about a newsletter that was calling for a short squeeze on a little Chinese stock, and today we’re again looking on the short side — though this time, it’s a short pick from Dan Amoss, who thinks he’s got the next NASDAQ stock that’s “headed straight for a body bag.” […]
This latest teaser ad is all about owning a “piece of an idea” — owning something valuable that gets you royalty payments, or payment for the “rental” of that idea. It’s a little bit similar to the old “Mainz Income” royalties, which were teased as a way to get recurring income that (we were told) […]
I’ve been getting a lot of questions about the latest “teaser video” from Patrick Cox for his Breakthrough Technology Alert — it’s the one that starts with a story about how “Robert has Alzheimer’s” and that a “breakthrough” gives him hope. And, of course, Cox will be “forced to remove” the presentation on November 11, […]
Focuses on special situation investing — spinoffs, buybacks, etc. Ceased publication when Mayer moved to Bonner & Partners.
Focuses on companies with hot new technologies, including biotech and technology stocks. Formerly run by Patrick Cox, who moved on to launch Transformational Technology Alert, a similar letter for Mauldin Economics.
Advisory service focused on energy and commodity investments, often very small junior resource companies.
Looks for winning microcap penny stocks, often extremely small. Seems to have replaced Penny Stock Fortunes at Agora Financial.
This monthly newsletter focuses on natural resources investments.
Edited by Chris Mayer, a stock picking newsletter that looks for undervalued and “hidden” stocks. Ceased publishing when Mayer left to write a couple new letters for Bonner & Partners.